nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy
|
Zelba, Henning |
|
2018 |
67 |
12 |
p. 1845-1851 |
artikel |
2 |
Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma
|
Yang, Chao |
|
2018 |
67 |
12 |
p. 1815-1823 |
artikel |
3 |
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma
|
Gray, Jhanelle E. |
|
2018 |
67 |
12 |
p. 1853-1862 |
artikel |
4 |
Cancer vaccine strategies: translation from mice to human clinical trials
|
Berzofsky, Jay A. |
|
2017 |
67 |
12 |
p. 1863-1869 |
artikel |
5 |
Cystatin F as a regulator of immune cell cytotoxicity
|
Kos, Janko |
|
2018 |
67 |
12 |
p. 1931-1938 |
artikel |
6 |
Dendritic cell trafficking in tumor-bearing mice
|
Krzastek, Sarah C. |
|
2018 |
67 |
12 |
p. 1939-1947 |
artikel |
7 |
Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies
|
Dobry, Allison S. |
|
2018 |
67 |
12 |
p. 1833-1844 |
artikel |
8 |
Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?
|
Haeryfar, S. M. Mansour |
|
2018 |
67 |
12 |
p. 1885-1896 |
artikel |
9 |
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment
|
Pilatova, Katerina |
|
2018 |
67 |
12 |
p. 1919-1929 |
artikel |
10 |
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)
|
Schmid, Sabine |
|
2018 |
67 |
12 |
p. 1825-1832 |
artikel |
11 |
Personalized cancer vaccines: adjuvants are important, too
|
Gouttefangeas, Cécile |
|
2018 |
67 |
12 |
p. 1911-1918 |
artikel |
12 |
Personalized cancer vaccines: adjuvants are important, too
|
Gouttefangeas, Cécile |
|
|
67 |
12 |
p. 1911-1918 |
artikel |
13 |
Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints
|
Shemesh, Avishai |
|
2017 |
67 |
12 |
p. 1871-1883 |
artikel |
14 |
Targeting CTCFL/BORIS for the immunotherapy of cancer
|
Loukinov, Dmitri |
|
2018 |
67 |
12 |
p. 1955-1965 |
artikel |
15 |
The role of CCR5 in directing the mobilization and biological function of CD11b+Gr1+Ly6Clow polymorphonuclear myeloid cells in cancer
|
Karin, Nathan |
|
2018 |
67 |
12 |
p. 1949-1953 |
artikel |
16 |
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
|
Rojas-Sepúlveda, Daniel |
|
2018 |
67 |
12 |
p. 1897-1910 |
artikel |